Mr. Lasersohn has thirty years of experience in health care venture capital investments. Prior to joining The Vertical Group’s predecessor, F. Eberstadt in 1981 as a member of its venture capital division, Mr. Lasersohn was a corporate attorney with Cravath, Swaine & Moore. Mr. Lasersohn has served on the boards of over thirty medical companies and currently serves on the Boards of Directors of Anova, Masimo Corporation, Oncomed, and Silk Road Medical. He previously served on the boards of Bacchus Vascular, CardioThoracic Systems, Inc., Cardiovascular Imaging Systems, Inc., E.P. Technologies, Integrated Vascular Systems, Kyphon Inc, Metabolix and Proteolix . Mr. Lasersohn served on the Executive Committee of the Board of Directors of the National Venture Capital Association and is a past Chairman of the Medical Industry Group of the NVCA . He was the recipient of the NVCA’s Outstanding Service Award in 2008. In 2011, Mr. Lasersohn was appointed by the Office of the President to serve as an Entrepeneur in Residence at the FDA to develop an Innovation Pathway for medical devices. In 2012 he was appointed by the Secretary of HHS as a guest panel member of the Medicare Coverage and Advisory Committee (MEDCAC). He received a B.S. degree in Physics from Tufts University, an M.A. from The Fletcher School of Law and Diplomacy, and a J.D. from Yale Law School.